1.Evaluation of Each Series of Lectures Using 10 Questions at the Sapporo Medical University School of Medicine
Hitoshi SOHMA ; Atsushi MIYAMOTO ; Hideo KANOH ; Kohzo IMAI ; Kowichi JIMBOW
Medical Education 2005;36(3):167-171
Every year since 2001 each series of lectures at the Sapporo Medical University School of Medicine has been evaluated using 10 questions with classification into five grades. In this study, the evaluation scores for 2001 and 2002 were compared and analyzed statistically. The average score for all subjects increased by 0.15 point in 2002. The average scores for liberal arts and clinical medicine increased 0.18 and 0.27 point, respectively, whereas the score for basic medicine increased 0.03 point, suggesting improvements with the efforts of each lecturer. The standard deviations of the scores for 8 questions (2 questions on examinations were omitted) were smaller for clinical medicine than for liberal arts and basic medicine. Continuous formative evaluation of each series of lectures and analysis of the results are needed to improve teaching skills.
2.Two Cases of Rare Venous Thromboembolism Experienced in Our Hospital
Tomonobu ABE ; Hiroshi NAKA ; Hisataka ONDA ; Atsushi IMAI ; Tomoko OKUYAMA ; Seigo TAKANO
Journal of the Japanese Association of Rural Medicine 2015;63(5):772-779
Case 1: A woman in her 70s was carried into emergency department of our hospital. Apparently she had dyspnea. Acute pulmonary heart was suspected. Electrocardiography S I Q III T III-pattern. The patient was diagnosed with popliteal vein vascular aneurysm by ultrasonography. Case 2: A man in his 60s, was referred to our hospital for treatment of lower extremity swelling and pain. Like Case 1, the male patient was suspected of having deep vein thrombosis and femoral artery aneurysms by ultrasound inspection and also diagnosed with pulmonary thromboembolism based on CT findings. We were able to rescue these two patients by rapid medical cooperation. Ultrasonography was particularly useful for diagnosis and morphological evaluation of blood vessels.
3.Early diagnosis of malignant-transformed ovarian mature cystic teratoma: fat-suppressed MRI findings.
Hiroshi TAKAGI ; Satoshi ICHIGO ; Takayuki MURASE ; Tsuneko IKEDA ; Atsushi IMAI
Journal of Gynecologic Oncology 2012;23(2):125-128
The most common form of malignant transformation developing from a mature cystic teratoma is squamous cell carcinoma, representing 80% of malignant transformations, while adenocarcinoma accounts for approximately 5%. Because of this rarity, few reports exist of preoperative diagnosis of this tumor by magnetic resonance imaging, in particular with fat suppression techniques. Here, we report magnetic resonance imaging findings and clinical features of a 79-year-old woman with mucinous adenocarcinoma arising from a mature cystic teratoma (measuring 5x6 cm), classified as surgical stage IA. Because of the poor prognosis of malignant transformation, when mature cystic teratomas are detected (even smaller than 5 cm tumor size) in postmenopausal women, serum tumor marker carcinoembryonic antigen levels and fat-suppressed magnetic resonance imaging may be potential indicators of malignant transformation.
Adenocarcinoma
;
Adenocarcinoma, Mucinous
;
Aged
;
Carcinoembryonic Antigen
;
Carcinoma, Squamous Cell
;
Early Diagnosis
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Prognosis
;
Teratoma
4.Validity and Reliability of Seattle Angina Questionnaire Japanese Version in Patients With Coronary Artery Disease.
Satomi SEKI ; Naoko KATO ; Naomi ITO ; Koichiro KINUGAWA ; Minoru ONO ; Noboru MOTOMURA ; Atsushi YAO ; Masafumi WATANABE ; Yasushi IMAI ; Norihiko TAKEDA ; Masashi INOUE ; Masaru HATANO ; Keiko KAZUMA
Asian Nursing Research 2010;4(2):57-63
PURPOSE: The aim of this study was to evaluate the validity and reliability of the Seattle Angina Questionnaire, Japanese version (SAQ-J) as a disease-specific health outcome scale in patients with coronary artery disease. METHODS: Patients with coronary artery disease were recruited from a university hospital in Tokyo. The patients completed self-administered questionnaires, and medical information was obtained from the subjects' medical records. Face validity, concurrent validity evaluated using Short Form 36 (SF-36), known group differences, internal consistency, and test-retest reliability were statistically analyzed. RESULTS: A total of 354 patients gave informed consent, and 331 of them responded (93.5%). The concurrent validity was mostly supported by the pattern of association between SAQ-J and SF-36. The patients without chest symptoms showed significantly higher SAQ-J scores than did the patients with chest symptoms in 4 domains. Cronbach's alpha ranged from .51 to .96, meaning that internal consistency was confirmed to a certain extent. The intraclass correlation coefficient of most domains was higher than the recommended value of 0.70. The weighted kappa ranged from .24 to .57, and it was greater than .4 for 14 of the 19 items. CONCLUSIONS: The SAQ-J could be a valid and reliable disease-specific scale in some part for measuring health outcomes in patients with coronary artery disease, and requires cautious use.
Asian Continental Ancestry Group
;
Coronary Artery Disease
;
Coronary Vessels
;
Humans
;
Informed Consent
;
Medical Records
;
Reproducibility of Results
;
Thorax
;
Tokyo
;
Surveys and Questionnaires
5.The current education program in all medical schools in Japan
Nobuo Nara ; Hiroshi Ito ; Masaaki Ito ; Miyuki Ino ; Yutaka Imai ; Masaru Kawasaki ; Keijiro Saku ; Toshiya Suzuki ; Mitsuru Seishima ; Takuzo Hano ; Saburo Horiuchi ; Masayuki Matsushita ; Atsushi Miyamoto ; Rika Moriya ; Masao Yamada ; Hitoshi Yokoyama
Medical Education 2016;47(6):363-366
The education program in all medical schools in Japan has been studied and analyzed every 2 years since 1974 by the curriculum committee of the Association of Japan Medical Colleges. Based on the most recent analysis in 2015, the marked innovation of medical education, such as an integrated curriculum, active learning, and clinical clerkship, was recognized.
6.Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
Shigeki BAMBA ; Osamu INATOMI ; Atsushi NISHIDA ; Masashi OHNO ; Takayuki IMAI ; Kenichiro TAKAHASHI ; Yuji NAITO ; Junichi IWAMOTO ; Akira HONDA ; Naohiro INOHARA ; Akira ANDOH
Intestinal Research 2022;20(3):370-380
Background/Aims:
Crosstalk between the gut microbiota and bile acid plays an important role in the pathogenesis of gastrointestinal disorders. We investigated the relationship between microbial structure and bile acid metabolism in the ileal mucosa of Crohn’s disease (CD).
Methods:
Twelve non-CD controls and 38 CD patients in clinical remission were enrolled. Samples were collected from the distal ileum under balloon-assisted enteroscopy. Bile acid composition was analyzed by liquid chromatography-mass spectrometry. The gut microbiota was analyzed by 16S rRNA gene sequencing.
Results:
The Shannon evenness index was significantly lower in endoscopically active lesions than in non-CD controls. β-Diversity, evaluated by the UniFrac metric, revealed a significant difference between the active lesions and non-CD controls (P=0.039). The relative abundance of Escherichia was significantly higher and that of Faecalibacterium and Roseburia was significantly lower in CD samples than in non-CD controls. The increased abundance of Escherichia was more prominent in active lesions than in inactive lesions. The proportion of conjugated bile acids was significantly higher in CD patients than in non-CD controls, but there was no difference in the proportion of primary or secondary bile acids. The genera Escherichia and Lactobacillus were positively correlated with the proportion of conjugated bile acids. On the other hand, Roseburia, Intestinibacter, and Faecalibacterium were negatively correlated with the proportion of conjugated bile acids.
Conclusions
Mucosa-associated dysbiosis and the alteration of bile acid composition were identified in the ileum of CD patients. These may play a role in the pathophysiology of ileal lesions in CD patients.
7.Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report
Takao MIWA ; Takahiro KOCHI ; Keitaro WATANABE ; Tatsunori HANAI ; Kenji IMAI ; Atsushi SUETSUGU ; Koji TAKAI ; Makoto SHIRAKI ; Naoki KATSUMURA ; Masahito SHIMIZU
Journal of Rural Medicine 2021;16(2):102-110
Objective: Lenvatinib is an oral multitarget tyrosine kinase inhibitor (mTKI) and is recommended for patients with advanced hepatocellular carcinoma (HCC) with Child-Pugh A liver function, who are not amenable to surgical resection, locoregional treatment, or transcatheter arterial chemoembolization. Hepatogastric fistula is a rare complication with a poor prognosis in patients with HCC. Previous reports on fistula formation during mTKI therapy for HCC were all associated with sorafenib. Here, we report the first case of recurrent hepatogastric fistula during lenvatinib therapy for advanced HCC managed using an over-the-scope clip (OTSC).Patient: We present the case of a 73-year-old man with alcoholic liver cirrhosis who was treated for multiple HCC for 7 years. HCC was treated using repetitive transcatheter arterial chemoembolization, radiofrequency ablation, and sorafenib. Owing to disease progression, lenvatinib treatment was started. During lenvatinib treatment, recurrent hepatogastric fistulas developed. An OTSC was useful for fistula closure and prevention of recurrence.Results: The major cause of fistula formation is considered to be the direct invasion of HCC; however, HCC treatment might also be a contributing factor in our case. In addition, OTSC was useful for fistula closure.Conclusion: Clinicians should be aware of the fatal complications during HCC treatment.
8.Appendix 1
Masao IWAGAMI ; Kotonari AOKI ; Manabu AKAZAWA ; Chieko ISHIGURO ; Shinobu IMAI ; Nobuhiro OOBA ; Makiko KUSAMA ; Daisuke KOIDE ; Atsushi GOTO ; Norihiro KOBAYASHI ; Izumi SATO ; Sayuri NAKANE ; Makoto MIYAZAKI ; Kiyoshi KUBOTA
Japanese Journal of Pharmacoepidemiology 2018;23(2):124-124
9.Appendix 2
Masao IWAGAMI ; Kotonari AOKI ; Manabu AKAZAWA ; Chieko ISHIGURO ; Shinobu IMAI ; Nobuhiro OOBA ; Makiko KUSAMA ; Daisuke KOIDE ; Atsushi GOTO ; Norihiro KOBAYASHI ; Izumi SATO ; Sayuri NAKANE ; Makoto MIYAZAKI ; Kiyoshi KUBOTA
Japanese Journal of Pharmacoepidemiology 2018;23(2):125-130
10.Appendix 3
Masao IWAGAMI ; Kotonari AOKI ; Manabu AKAZAWA ; Chieko ISHIGURO ; Shinobu IMAI ; Nobuhiro OOBA ; Makiko KUSAMA ; Daisuke KOIDE ; Atsushi GOTO ; Norihiro KOBAYASHI ; Izumi SATO ; Sayuri NAKANE ; Makoto MIYAZAKI ; Kiyoshi KUBOTA
Japanese Journal of Pharmacoepidemiology 2018;23(2):131-139